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Abstract Activation of nuclear factor kappa B (NF-κB) is
accomplished by a specific kinase complex (IKK-complex),
phosphorylating inhibitors of NF-κB (IκB). In embryonic
stem cells (ESCs), NF-κB signaling causes loss of pluripo-
tency and promotes differentiation towards a mesodermal
phenotype. Here we show that NF-κB signaling is involved
in cell fate determination during retinoic acid (RA) mediated
differentiation of ESCs. Knockdown of IKK1 and IKK2
promotes differentiation of ESCs into neuroectoderm at the
expense of neural crest derived myofibroblasts. Our data
indicate that RA is not only able to induce neuronal differ-
entiation in vitro but also drives ESCs into a neural crest cell
lineage represented by differentiation towards peripheral
neurons and myofibroblasts. The NC is a transiently exist-
ing, highly multipotent embryonic cell population generat-
ing a wide range of different cell types. During embryonic
development the NC gives rise to distinct precursor lineages
along the anterior-posterior axis determining differentiation
towards specific derivates. Retinoic acid (RA) signaling
provides essential instructive cues for patterning the neuro-
ectoderm along the anterior-posterior axis. The demonstra-
tion of RA as a sufficient instructive signal for the
differentiation of pluripotent cells towards NC and the in-
volvement of NF-κB during this process provides useful
information for the generation of specific NC-lineages,
which are valuable for studying NC development or disease
modeling.
Keywords NF-κB . Neural crest . Embryonic stem cells .
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Introduction
NF-κB is a central regulator of different fundamental cellular
processes like apoptosis, cell adhesion, inflammation,
immune-response, tissue remodeling and proliferation [1–3].
The mammalian NF-ĸB family consists of five subunits that
are able to generate a variety of homo- and hetero- dimeric,
DNA-binding complexes. DNA-binding and dimerization is
mediated by an N-terminal domain called the Rel-homology
domain (RHD) which is shared by all NF-κB subunits. Only
the Rel subfamily, p65 (enconded by relA), RelB and c-Rel
contain a transactivation domain enabling transcriptional ac-
tivation. In contrast, p50 and p52 lack a transactivation do-
main. These two subunits cannot activate transcription unless
they are partnered to p65, RelB or c-Rel. Furthermore, both
p50 and p52 are synthesized from their longer precursors p105
and p100 by proteolytic cleavage [2].
In most unstimulated mammalian cells, NF-ĸB is pre-
dominantly located within the cytoplasm bound to its inhib-
itor, a family of proteins called IĸBs (Inhibitor of kappa B),
which mask the nuclear localization signal (NLS) within the
RHD domain of the NF-ĸB subunits and prevent transloca-
tion of NF-ĸB to the nucleus [2].
Activation of NF-ĸB is obtained by various stimuli which
cause degradation of IĸBs, followed by translocation of NF-
ĸB to the nucleus and activation of its target genes. Several
distinct differences in the activation of NF-κB allow a
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classification of NF-κB in distinct signaling pathways.
Among them, canonical NF-κB signaling is the most com-
mon and best characterized NF-κB pathway. During canon-
ical signaling IĸBα is phosphorylated by the IKK complex,
which consists of two catalytic subunits IKK1 and IKK2
(IĸB kinases alpha and beta, respectively) and NEMO, a
non-catalytic subunit. Upon stimulation the IKK complex is
activated, which causes phosphorylation of IĸBα at two N-
terminal serine (Ser32 and Ser36) residues by IKK2.
Subsequently IĸBα is ubiquitinilated and degraded by the
26S proteasome leading to the translocation of NF-κB to the
nucleus and activation of its target genes [2].
Previous studies indicated an upregulation of canonical
NF-κB signaling during retinoic acid (RA) mediated differ-
entiation of embryonic stem cells (ESCs) suggesting a po-
tential role of NF-κB during ESC differentiation [4–6].
Recently, it was demonstrated that overexpression of NF-
κB partially mimics the effect of RA and causes differenti-
ation of ESCs towards a mesodermal phenotype. Like treat-
ment with RA, canonical NF-κB signaling leads to the
induction of Zeb1 and Slug, markers for an epithelial to
mesenchymal transition (EMT), as well as to massive
changes in the cellular morphology [5]. These data suggest
the participation of NF-κB in RA mediated cell fate deter-
mination, which is investigated in more detail in this study.
RA is widely used to induce neuronal differentiation of
pluripotent cells in vitro [7–9], though in vivo studies indi-
cated that RA signaling is not required for neural induction
[10–12]. In the developing mouse embryo RA is not syn-
thesized until E7.5, which is after induction of the neural
ectoderm [13]. Furthermore, loss of RA-signaling does not
hamper the expression of early neural markers like Sox1 and
Sox2 [11]. Instead, during early stages of development, RA-
signaling is required for further patterning of the posterior
neuroectoderm (hindbrain and spinal cord) [11, 12] and a
wide range of other developmental processes [14].
Among the transgenic mice with disruptions of enzymes
involved in RA synthesis, the strongest phenotype is ob-
served in Raldh2 knockout mice, which die at E9.5 with an
incomplete closure of the neural tube [12]. Other animal-
models lacking components of RA-signaling also display
severe phenotypes, with defects in NC derivates, among
others. Loss of Rdh10 results in craniofacial defects with
an abnormal formation of cranial ganglia and defects in
neural crest patterning [15]. Mutant embryos lacking both
RALDH1 and RALDH3 show defects in the neural crest
derived perioptic mesenchym which is crucial for a proper
morphogenesis of the eye [16].
These in vivo studies indicate that RA signaling contrib-
utes to the specification of the NC, which takes place during
the gastrulation phase at the border between the future
neural tube and the epidermis. Later during neurulation,
the NC precursors are located within the elevated neural
folds and the dorsal parts of the neural tube, from which
they delaminate and subsequently migrate. Neural crest cells
(NCCs) are highly multipotent and give rise to many differ-
ent cell types including neurons and glia of the peripheral
neurvous system, melanocytes, bone and cartilage cells and
smooth muscle cells.
Recent studies indicated that some NCCs still persist in
adulthood, especially in a number of craniofacial tissues
[17–19]. Their high regenerative potential and high degree
of multipotency makes neural crest derived adult stem cells
a valuable source for adult stem cells with potential appli-
cation for regenerative medicine [20].
Other in vitro studies using pluripotent stem cells also
suggested that RA-signaling is implicated in the directed
differentiation of pluripotent stem cells towards NCCs
[21–23], providing a desirable tool for studying NC devel-
opment, cell fate determination and migration. NCCs de-
rived from patient-specific induced pluripotent stem cell
(iPSCs) even enable modeling of human diseases [24].
In this study we report that treatment of mouse ESCs with
RA is sufficient to induce differentiation towards a NC like
phenotype, whose further specification depends on NF-κB
signaling, which has not been described yet. Our data provide
new insight into themechanism of NC specification andmight
be helpful for the directed differentiation or even program-
ming of other cell populations towards specific NC lineages
with a defined identity along the anterior-posterior axis.
Results
Generation of Neural Crest Precursors from Embryonic
Stem Cells by Treatment with RA
Previous reports showed that RA signaling is able to induce
a neural differentiation in vitro [7–9]. The impact of RA on
the generation of NCCs remains quite elusive with only a
few studies available addressing this issue [21, 22].
To study the effect of RA during ESC differentiation,
cells were cultivated for 8 days in suspension as embryoid
bodies (EBs) without LIF and RAwas applied at the 4th and
6th day of differentiation. After 8 days, EBs were either
plated in EB-medium containing 10 % FCS or serum-free
N2B27 medium and stained for Tuj1 and Peripherin. Tuj1
was used as a general marker for neurons, whereas
Peripherin only labels the subclass of peripheral neurons.
In contrast to the effect of N2B27 medium, which yielded a
large amount of Tuj1+ cells with only a poor overlap to
Peripherin (Fig. 1a), plating of EBs in the presence of serum
resulted in a fewer number of Tuj1+ cells, with a high
amount of Tuj1+/Peripherin+ cells. We also observed a large
number of migrating cells in the presence of serum, which
were hardly detectable in N2B27 medium.
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To further investigate the effect of serum on the resulting
phenotype, cells were stained for the neural crest marker
AP2α to examine the presence of NCCs. AP2α+ as well as





























Fig. 1 Retinoic acid promotes expression of markers associated with
an EMT during ESC differentiation. (a) Peripherin and Tuj1 stainings
of EBs 5 days after plating in media containing either 10 % FCS or N2
and B27. Asterisks indicate migrating cell populations. Scale bar:
200 μm. Scale bar, All insets: 50 μm (b) EBs were plated in medium
containing 10 % FCS and immunohistochemically analyzed 2 days and
5 days after plating. Negative data for Otx2 are not shown. Scale bars:
50 μm. (c) qPCR analysis of different EMT and NC markers during
RA induced differentiation of ESCs. Data indicate mean ± SD of one
experiment performed as triplicate representing at least two indepen-
dent experiments. In all experiments RAwas applied after 4 and 6 days
of EB formation. For immunohistochemical analysis in (a) and (b) EBs
were plated 8 days after formation and further cultivated as indicated
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cell population at the border of plated EBs (Fig. 1b). 5 days
after further cultivation we were able to detect SMA+ cells
and MAP2+ cells indicating the presence of both, the mes-
odermal and ectodermal lineage. To specify the identity of
the neuronal cells more detailed, antibodies for Islet1, Otx2
and Peripherin were applied (Fig. 1b). The presence of
Islet1+ cells as well as of Islet1+/Peripherin+ cells indicates
NC derived peripheral neurons with a dorsal root ganglia
(DRG) identity (Fig. 1b). In contrast, Otx2+ cells, which
indicate progenitors with a forebrain and midbrain identity,
were not detectable reflecting the caudalizing effect of RA.
Our data so far suggest that RA treatment results in a NC
like intermediate which is able to differentiate into cells of
the PNS as well as SMA+ myofibroblasts in the presence of
serum. It is not likely, that the obtained SMA+ cells are
directly derived by mesodermal precursors since RA inhibits
mesodermal differentiation [21].
During delamination from the neural tube, NCCs under-
go an epithelial to mesenchymal transition (EMT), which
involves massive cytoskeletal rearrangements and morpho-
logical changes towards a motile cell phenotype enabling
migration and specification of their different derivates [25,
26]. This is an essential process for the generation and
specification of the NC and their derivates during
development.
To examine the effect of RA at the transcriptional level,
expression of different EMT and NC markers was investi-
gated using qPCR. Treatment with RA resulted in an induc-
tion of NC and EMT markers Slug (snai2), Twist (twist1),
Vimentin (vim), Zeb1, and Pax6 whereas E-cadherin (cdh1)
expression markedly decreased upon RA treatment. mRNA
levels of Snail (Snai1) seemed not to be upregulated upon
RA treatment (Fig. 1c), though Snail is one of the major
inductors of an EMT. The second member of the Zeb family,
Zeb2, was slightly downregulated after treatment with RA
(Fig. 1c).
The induction of several key EMT- and NC markers after
RA treatment indicates that RA not only induces the differ-
entiation towards a neuroepithelium by activating Pax6
expression, but also promotes an upregulation of some
EMT markers at the transcriptional level which might result
in the generation of a NC like phenotpye.
To further characterize the effect of RA during ESC
differentiation the expression of several markers was com-
pared between RA treated cells and untreated controls. Four
days after EB-formation, cells were either treated for 4 days
with RA or left untreated. In order to quantify the expression
pattern, EBs were dissociated to single cells and stained for
the markers indicated (Fig. 2).
One day after dissociation 25.1 % and 55.1 % of the RA-
treated cells were positive for the transcriptions factors
Ap2α and Pax3, respectively, whereas 50.3 % were positive
for p75. To investigate the presence of NE precursors,
dissociated EBs were also stained for Pax6, which was
expressed in 28.3 % of the RA-treated cells (Fig. 2a).
None of the markers mentioned above could be detected in
untreated controls, indicating that these cells rather represent
an undifferentiated phenotype (Fig. 2a).
After dissociation untreated cells also displayed a more
densely packed morphology and tended to grow in patches,
in contrast to RA treated cells, which showed a more even
distribution with mostly a wide spread morphology. This
was also reflected by the expression of the intermediary
filament Vimentin. 81.5 % of the RA treated cells showed
a cytoskeleton built from Vimentin, whereas in untreated
cells Vimentin filaments were only detectable to a lesser
extent (18.2 %) (Fig. 2a).
Five days after plating 22.68 % of the cells treated with
RAwere TUJ1+ and 39.82 % showed an expression of SMA
(Fig. 2b). In contrast only 6.4 % of the untreated controls
expressed SMA and none of the cells left untreated were
TUJ1+ (Fig. 2b).
Though our data do not demonstrate the generation of
bona fide NCCs by RA treatment of ESCs, they provide
strong evidence that RA promotes the expression of several
NC markers as well as the expression of some markers for
an EMT. Additionally, the difference in the cellular mor-
phology between RA treated cells and untreated controls
further indicate that RA participates in promoting an EMT,
resulting in a Vimentin+, NC like phenotype.
The presence of cells positive for NC markers as well as
Pax6+ cells indicates a mixed population of precursor cells,
which enables the generation of both the mesodermal and
neueoectodermal lineage during maturation of the progeni-
tor cells in the presence of serum.
Inhibition of NF-κB Signaling Promotes Neuronal
Differentiation at the Expense of Mesoderm
Recent studies suggested a role for NF-κB signaling during
differentiation of ESCs, indicating that NF-κB is able to
promote an EMT of ESCs which causes loss of pluripotency
[5, 6]. To explore the impact of NF-κB during the process of
cell fate determination, we generated a lentivirus-based vec-
tor to deliver two U6-promoter driven short-hairpin RNA
(shRNA) cassettes producing a simultaneous knockdown of
both IKKs (inhibitor of NF-kappa B kinases) (Fig. 3c).
NF-κB belongs to an inducible family of transcription
factors, whose activation relies on phosporylation of its
inhibitor, a protein family called IκBs (inhibitor of NF-
kappa B). The IKK complex, consisting of IKK1, IKK2
and a non-catalytic subunit NEMO, is necessary for activa-
tion of NF-κB signaling and results in phosphorylation and
subsequent degradation of IκB. Simultaneous knockdown
of both IKKs therefore does not restrict the inhibition of NF-
κB to one subunit.
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Fig. 2 Neural crest related markers are expressed upon retinoic acid
mediated differentiation of ESCs. (a) RA treated or untreated EBs were
immunohistochemically analysed for p75, AP2α, Pax3, Pax6 and
Vimentin 1 day after dissociation. Though in untreated cells Vimentin
expression was detectable in form of non-filamentous cluster (inset),
Vimentin filaments were only detectable in the minority of the cells
(indicated by arrowheads). Scale bar: 100 μm. (b) 5 days after disso-
ciation of RA treated or untreated EBs, cells were labeled for SMA and
Tuj1. Scale bar: 200 μm. RA was applied after 4 and 6 days of EB
formation as indicated. Dissociation of EBs was performed after 8 days
of cultivation in suspension. For quantification of immunohistochem-
ical analysis >300 cells were evaluated. Data indicate Mean ± SD
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Different shRNAs were tested for their potential to re-
duce the protein levels of IKK1 and IKK2 in HEK 293FT
cells, respectively. Flag-tagged IKK1 or IKK2 were co-
expressed together with each shRNA (Fig. 3a and b) and
for each kinase a functional sequence was selected and a
“double-knockdown” vector was generated (Fig. 3c and d).
Two non-functional sequences served as control.
After transduction, ESCs were expanded as a polyclonal
cell-line and subsequently differentiated as EBs (Fig. 3e).
For validation of a successful knockdown of IKK1 and
IKK2, the expression level of both kinases was assayed by
qPCR after 8 days of differentiation. In both cases a reduc-
tion in the mRNA expression could be detected (Fig 3f). The
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investigated after ESC differentiation. Since the IKK-
complex phosphorylates IκBα, which is subsequently de-
graded by the proteasome and thereby causes an activation
of NF-κB, we investigated the phosphorylation of IκBα.
After 8 days of differentiation as EBs and treatment with
RA, reduced levels of phosphorylated IκBα could be ob-
served upon knockdown of both IKKs (Fig 3g), indicating a
functional impairment of NF-κB signaling.
To confirm the maintenance of pluripotency after trans-
duction of ESCs and knockdown of IKK1 and IKK2, Oct4
stainings were carried out (Fig. 3f). ESCs expressing either
both functional sh-RNAs or the corresponding control sh-
RNAs were positive for Oct4, demonstrating that knock-
down of IKK1 and IKK2 had no obvious effect on self-
renewal and pluripotency of ESCs (Fig. 3f). For further
characterization of knockdown ESCs, the expression of
oct4 and nanog was monitored during RA induced differ-
entiation by qPCR (Fig. 3g). Expression of both pluripo-
tency markers was slightly enhanced in the undifferentiated
state and the downregulation of oct4 and nanog was delayed
during the first days of differentiation upon LIF withdrawal.
Nevertheless, knockdown of IKK1 and IKK2 did not medi-
ate any resistance to RA induced ESC differentiation.
Treatment with RA caused a dramatic drop in the expression
of both pluripotency markers (Fig. 3g).
These observations confirm previous data demonstrating
that overexpression of a dominant negative form of IκBα
caused a slight delay in the expression of Nanog after LIF
withdrawal [6]. This is in agreement with the notion that
NF-κB signaling is repressed during pluripotency and upre-
gulated upon differentiation [5, 6].
To investigate the effect of inhibiting NF-κB signaling
during RA induced differentiation, Pax6 and different
markers characteristic for an EMT were assayed by qPCR
as well. A significant downregulation in the expression of
Snail, Twist, Vimentin and Zeb1 could be detected (Fig. 3f).
Previous studies already demonstrated a NF-κB dependent
regulation of these genes, indicating a reduced transcription-
al activity of κB-targets after knockdown of IKK1 and
IKK2.
Next, the effect on cell fate determination during RA
mediated differentiation of ESCs was investigated. Five
days after dissociation of EBs cells were stained for SMA,
Tuj1and Islet1 (Fig. 4a, b and c) and the number of positive
cells was quantified (Fig. 4d). To measure the effects of sh-
RNA expression only, GFP+ cells were evaluated. Upon
NF-κB inhibition a shift from SMA+ cells towards Tuj1+
cells as compared to the control was observed. The number
of SMA+ cells decreased from 46.37 % to 24.66 %, whereas
the number of Tuj1+ cells increased from 23.41 % to
47.96 % (Fig. 4c). In contrast, significant differences in
the number of Islet1+ cells were not detectable (Fig. 4d).
The remaining cells that were neither positive for Tuj1 nor
SMA, might represent a mixture of undifferentiated precur-
sors, differentiated cells of another phenotype or ESCs that
still remained pluripotent and were not further investigated.
In summary, we demonstrate in accordance with [22] that
RA-treatment can be used to generate NCCs from ESCs. An
increase of the amount of neuronal cells at the expense of a
mesodermal phenotype was detectable upon inhibition NF-
κB signaling, indicating a role for NF-κB signaling in cell
fate determination during RA-induced differentiation of plu-
ripotent cells.
Discussion
Understanding the mechanisms underlying the specification
of the NC provides essential information for the generation of
lineage specific NC-precursors with a defined identity along
the anterior-posterior axis. Our study demonstrates that RA-
signaling is one of the pathways triggering the induction of
NC identity. Further investigations might reveal, whether the
generation of RA-treatment directly triggers the differentiation
of ESCs into NCCs or if RA rather induces a neuroepithelial
phenotype and derivation of NCCs is a secondary effect
promoted by intrinsic cues resembling the in vivo situation
with a NC specification at the border between neuroectoderm
and non-neural ectoderm. The fact that treatment of EBs with
RA creates a gradient, with the highest RA concentration at
the outside, indicates that only those cells exposed to certain
RA-concentrations generate NC.
Fig. 3 Knockdown of IKK1 and IKK2 in ESCs. (a, b) Western blots
were carried out after co-expression of flag-tagged IKK1 (a) or IKK2
(b) with the indicated sh-sequences in HEK 293FT cells. (c) Lentiviral
vector for inhibition of NF-κB signaling by knockdown of IKK1 and
IKK2. LTR, long terminal repeat. WRE, woodchuck post-
transcriptional regulatory element. hUbiQ, human Ubiquitin C promot-
er. U6, murine U6 promoter. (d) Validation of the lentiviral vector.
Western blots were performed after ectopic co-expression of Flag-
tagged IKK1 and IKK2 together with the lentiviral vector in HEK
293FT cells. (e) J1 ESCs, transduced with the lentiviral vectors indi-
cated, were differentiated as EBs. Scale bar: 200 μm. (f) To validate the
knockdown of IKK1 and IKK2, qPCR were carried out after differen-
tiation of ESCs as EBs. Data represent mean ± SEM of three indepen-
dent experiments, each performed as triplicate. (g) Knockdown of
IKK1 and IKK2 results in reduced levels of phosphorylated IκBα.
ESCs were differentiated for 8 days as EBs and treated with RA after 4
and 6 days. Proteins were extracted after 8 days and Western blots were
performed. (h) Oct4 stainings of transduced ESCs to confirm mainte-
nance of pluripotency after knockdown of IKK1 and IKK2. Feeder
cells were also stained by DAPI, but negative for Oct4 and GFP. Scale
bar: 50 μm. (i) Expression levels of oct4 and nanog during differenti-
ation of ESCs as EBs. After 4 days cells were treated with RA. Data
indicate mean ± SD of one experiment performed as triplicate repre-
senting two independent experiments. (j) Effect of NF-κB inhibition
assayed by qPCR. After transduction of J1 ESCs, cells were differen-
tiated as EBs and treated for 4 days with RA. At the day of EB
dissociation samples were collected and different markers were
assayed. Data represent mean ± SEM of three independent experi-
ments, each performed as triplicate
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Indeed, previous reports using Sox10-GFP reporter cell-line
already suggested that only specific concentration of RA are
able to induce a NC cell fate [22]. Further investigation and
manipulation of other signaling pathways in addition to different
RA concentrations may provide further details for the specifica-
tion of NC and the generation of stabile NC precursors.
Our data also suggest a role for NF-κB during this




Stem Cell Rev and Rep (2012) 8:1098–1108 1105
induced ESC differentiation resulted in a shift from a mes-
odermal phenotype towards an ectodermal one. Inhibition of
NF-κB signaling seems to interfere with the specification of
ESCs towards a SMA+ phenotype resulting in an increased
amount of Tuj1+ cells.
There is either the possibility that reduced activation of
NF-κB acts during early cell specification, resulting in an
enhanced number of NE precursors or NF-κB activation is
necessary for the specification of NC derived SMA+ cells in
later stages of differentiation. The unaltered amount of NC
derived Islet1+ cells might indicate that low levels of acti-
vated NF-κB results in an increased amount of NE precur-
sors, favoring the first possibility. Furthermore, previous
studies already demonstrated that NF-κB signaling is al-
ready upregulated 1 day after treatment with RA, which
also indicates that NF-κB rather act during initial differen-
tiation steps [6]. We also observed a downregulation of
different EMT markers upon inhibition of NF-κB signaling,
also supporting the notion that dysregulated NF-κB signal-
ing effects the specification of the precursor due to reduced
transcriptional activity of κB-targets. A more detailed anal-
ysis using linage tracing or inducible promoters to repress
NF-κB signaling might address this question and would
provide further insight into the effect of NF-κB signaling
on cell fate specification in vitro.
In vivo, transgenic animals with disruptions of single NF-
κB subunits show no developmental defects [27, 28], but
mice double deficient for IKK1 and IKK2 [29] as well as
knockout of Bcl10, a receptor interacting protein which is
crucial for full activation of IKKs, show a neural tube
closure defect [30]. Notably, such a defect is also observed
in knockout mice for Ap2α, Pax3 and Pax7, factors which
are essential for the specification of the neural crest [31, 32].
In agreement with the notion that NF-κB is a positive
regulator for Twist and Snail [33], knockout of Twist1 results
in strong developmental defects of neural crest derivates
[33], whereas in Snail deficient mice the mesoderm retains
an epithelial characteristic. This demonstrates the impor-
tance of Snail in inducing an EMT [34], which is crucial
for the generation of the neural crest.
The Drosophila orthologue of NF-κB, dorsal, is essential
for patterning the dorsal-ventral axis during development
[35]. Briefly, high levels of Dorsal determine the presump-
tive mesoderm by activating Snail and Twist, whereas lower
levels result in neuroectoderm [36] (Fig. 4e). Since Bilateria
show a common plan for patterning the dorsoventral axis
[37], in mammals, a NF-κB gradient might be necessary for
establishing the neural crest. Here we show that knockdown
of IKK1/2 reduces NF-κB target gene expression (Twist,
Snail). This might result in an intermediate level of NF-κB
activation, promoting the formation of neuroectoderm
(Fig. 4f). In accordance with this model, we hypothesize
that knockdown of IKK1/2 reduces differentiation towards
NCCs, a cell populations with high NF-κB activity. We
conclude that a Drosophila gene cascade of the dorsal
complex might have a similar function in mammalian
development.
Material & Methods
Cell Culture, Differentiation & Transfection
J1 ESCs were cultured on Mitomycin C inactivated mouse
embryonic fibroblasts (MEFs) in ESC medium consisting of
Dulbeccos-Minimum Essential Medium (DMEM; PAA)
supplemented with 15 % fetal calf serum (FCS; Gibco),
1,000 U/ml LIF (Millipore), 1× non-essential amino acids
(PAA), 2 mM L-glutamine (PAA), 1× Penicillin/
Streptomycin (PAA) and 150 μM β-mercaptoethanol.
For differentiation, ESCs were cultured in suspension as
EBs in EB-medium and treated with retinoic acid (5 μm,
Sigma-Aldrich) at the 4th and 6th day of differentiation. EB-
medium consisted of DMEM containing 10 % FCS (Gibco),
1× non-essential amino acids (PAA), 2 mML-glutamin (PAA),
1× Penicillin/Streptomycin (PAA) and β-mercaptoethanol.
After 8 days EBs were either plated in EB-medium or
serum-free N2B27-medium consisting of a 1:1 mix of
Neurobasal (Invitrogen) and DMEM/F12 (Invitrogen) me-
dia supplemented with 0.5× N2 (Invitrogen), 0.5× B27
(Invitrogen), 1× non-essential amino acids (PAA), 2 mM
L-glutamine (PAA), 1× Penicillin/Streptomycin (PAA).
HEK 293FT cells were cultivated in DMEM containing
10 % FCS and transfected with Turbofect (Fermentas)
according to the manufactures’ instructions. For co-
expression of flag-tagged IKK1 and IKK2 (600 ng) with
each sh-expression vector (2,400 ng), 1×106 cells per cm2
were plated on 6-well plates and directly transfected after
plating. In all transfections, 3 μl Turbofect was used and the
Fig. 4 NF-κB promotes RA mediated differentiation of ESCs into
neuroectoderm at the expense of mesoderm. (a–c) Four days after
formation of EBs, cells were treated for 4 days with RA and dissociated
after 8 days of differentiation. Five days after dissociation of EBs and
replating, cells were stained for SMA (a), Tuj1 (b) and Islet1 (c). Scale
bar: 200 μm. (d) Quantification of immunostainings. Only GFP+ cells
were evaluated. Data show mean ± SD of three independent experi-
ments; >750 cells were quantified. (e) Scheme of a cross-sectioned
Drosophila embryo. Nuclei within the syncytium are either with high
level of nuclear Dorsal (black, ventral side), intermediate levels of
nuclear Dorsal (grey) or with no nuclear dorsal (white). High levels
of dorsal activate target genes Twist and Snail, necessary for mesoderm
formation, whereas neuroectoderm is formed with intermediate levels
of dorsal. (f) Hypothetical pathway of cell fate induction by NF-κB in
mESCs. ESCs are devoid of translated NF-κB [4]. Forced expression
of NF-κB resulted in the formation of mesoderm [4], whereas this
study indicates that knockdown of IKK1 and IKK2 enhanced the
formation of neuroectoderm. ES: Embryonic stem cells; NC: Neural
crest cells; NE: Neuroepithelial cells
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total amount of DNA was kept constant by addition of the
according empty vector.
RT-PCR and qPCR
For quantification of mRNA total RNA was prepared using
RNAeasy RNA Kit (Qiagen). 1 μg of total RNAwas treated
with DNAse I (Fermentas) and subsequently reverse tran-
scribed with First strand cDNA synthesis Kit (Fermentas).
1 μl of 1:5 diluted cDNAwas used as template per reaction.
Each reaction was performed as triplicate.
All qPCR reactions were performed using Platinum
SYBR Green qPCR Super-Mix UDG (Invitrogen) and
assayed with a Rotor Gene 6000 (Corbett).
Western Blot
Cells were extracted in lysis-buffer (1 % SDS, 5 mM EDTA,
complete protease inhibitor cocktail (Roche)) directly in the
dish on ice. Subsequently extracts were boiled for 5 min at
95 °C. Equal amounts of protein extracts were separated on
a 10 % SDS-PAGE and transferred to nitrocellulose mem-
branes (PALL). Membranes were blocked in PBS with 5 %
milk powder and 0,05 % Tween for 1 h at 37 °C. Blots were
probed with primary antibodies overnight and incubated
with horseradish peroxidase-conjugated secondary antibod-
ies the next day for 1 h. Western blots were carried out using
GAPDH (Santa Cruz, sc-32233), pospho IκBα (Ser 32/36)
(Cell Signaling, 5A5) and Flag (Sigma Aldrich; F7425)
primary antibodies and developed using ECL (enhanced
chemiluminescence).
Lentivirus Production
Lentivirus production was perfomed by co-transfection of
293FT cells using calcium-phosphate precipitation. One day
before transfection 1×107 cells were plated on a 15 cm dish.
The next day cells were transfected with 50 μg of the
transfer vector indicated, 37,5 μg Δ8.91 and 15 μg VSV-
G helper plasmids. 16–24 h later medium was changed and
60–72 h after transfection the supernatant was harvested and
stored at −80 °C or used immediately for concentration by
ultracentrifugation (50.000 g, 2 h, 4 °C).
Immunostainings
Cells were fixed with 4 % paraformaldehyde in PBS for
15 min at room temperature, permeabilized for 10 min with
0,1 % Triton-X-100 in PBS, blocked for 45 min in 2 %
bovine serum albumin (BSA) and incubated with the pri-
mary antibody for 2 h at room temperature. Incubation with
the appropriate Alexa-conjugated secondary antibody
(Invitrogen) was performed at room temperature for 1 h.
DAPI was used as counterstain. Immunostainings were car-
ried out with Pax3 (DSHB), Pax6 (DSHB), p75 (Millipore;
AB1554), AP2α (DSHB; 3B5), Islet11 (DSHB; 40.2D.6),
Otx1 (DSHB; 5F5), MAP2 (Millipore; AB5622), Tuj1
(Promega; 5G8), Smooth Muscle Actin (SMA) (Sigma-
Aldrich; 1A4), Peripherin (Millipore, AB 1530) and
Vimentin (DSHB, 40E-C) primary antibodies.
Plasmid Construction
To generate IKK1 and IKK2 knockdown plasmids, different
sh-sequences were synthesized as sense and antisense oligos
and cloned into ApaI and EcoRI restriction sites of psilencer
U6-1.0. A unique NheI restriction site was introduced at the
3′ end of the oligos. After validation of different sequences,
one functional and non-functional sequence was selected for
each kinase and subsequently introduced into FG12 [38].
Following sequences were used for the simultaneous knock-
down: IKK1; 5′ CAGCCTTTGTAGTTTAATA 3′ (sequence
H), IKK2; 5′ GGACATCGTTGTTAGTGAA 3′ (sequence
E). As a control, two non-functional sequences were used:
IKK1; 5′ GCATGAATGTGTCTCGACT 3′ (sequence F),
IKK2; 5′ TGACGTGAAGCATCTAGTA 3′ (sequence D).
An XbaI and NheI fragment, consisting of U6 promoter, sh-
sequence and termination signal was cloned into the XbaI
restriction site of FG12. During introduction of the first sh-
cassette the NheI restriction site was destroyed and the XbaI
restriction site could be used again, for introduction of the
second sh-cassette.
Acknowledgments We are grateful to A. Kralemann-Köhler for
excellent technical assistance; we thank C. Haubenreich and P. Hei-
mann for critical discussion and helpful comments on the manuscript.
This study was supported by the University of Bielefeld and the DFG.
Conflicts of interest The authors declare no potential conflicts of
interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, distri-
bution, and reproduction in any medium, provided the original author(s)
and the source are credited.
References
1. Ben-Neriah, Y., & Karin, M. (2011). Inflammation meets cancer,
with NF-kappaB as the matchmaker. Nature Immunology, 12, 715–
723.
2. Hayden, M. S., & Ghosh, S. (2008). Shared principles in NF-
kappaB signaling. Cell, 132, 344–362.
3. Kaltschmidt, B., & Kaltschmidt, C. (2009). NF-kappaB in the
nervous system. Cold Spring Harbor Perspectives in Biology, 1,
a001271.
4. Kim, Y. E., Kang, H. B., Park, J. A., Nam, K. H., Kwon, H. J., &
Lee, Y. (2008). Upregulation of NF-kappaB upon differentiation of
mouse embryonic stem cells. BMB Reports, 41, 705–709.
Stem Cell Rev and Rep (2012) 8:1098–1108 1107
5. Lüningschrör, P., Stöcker, B., Kaltschmidt, B., Kaltschmidt, C.
(2012). miR-290 cluster modulates pluripotency by repressing
canonical NF-kappaB signaling. Stem Cells.
6. Torres, J., & Watt, F. M. (2008). Nanog maintains pluripo-
tency of mouse embryonic stem cells by inhibiting NFkappaB
and cooperating with Stat3. Nature Cell Biology, 10, 194–
201.
7. Bain, G., Kitchens, D., Yao, M., Huettner, J. E., & Gottlieb, D. I.
(1995). Embryonic stem cells express neuronal properties in vitro.
Developmental Biology, 168, 342–357.
8. Bibel, M., Richter, J., Schrenk, K., et al. (2004). Differentiation of
mouse embryonic stem cells into a defined neuronal lineage.
Nature Neuroscience, 7, 1003–1009.
9. Fraichard, A., Chassande, O., Bilbaut, G., Dehay, C., Savatier, P.,
& Samarut, J. (1995). In vitro differentiation of embryonic stem
cells into glial cells and functional neurons. Journal of Cell
Science, 108(Pt 10), 3181–3188.
10. Molotkova, N., Molotkov, A., & Duester, G. (2007). Role of
retinoic acid during forebrain development begins late when
Raldh3 generates retinoic acid in the ventral subventricular zone.
Developmental Biology, 303, 601–610.
11. Molotkova, N., Molotkov, A., Sirbu, I. O., & Duester, G. (2005).
Requirement of mesodermal retinoic acid generated by Raldh2 for
posterior neural transformation. Mechanisms of Development, 122,
145–155.
12. Niederreither, K., Subbarayan, V., Dolle, P., & Chambon, P.
(1999). Embryonic retinoic acid synthesis is essential for early
mouse post-implantation development. Nature Genetics, 21,
444–448.
13. Rossant, J., Zirngibl, R., Cado, D., Shago, M., & Giguere, V.
(1991). Expression of a retinoic acid response element-hsplacZ
transgene defines specific domains of transcriptional activity dur-
ing mouse embryogenesis. Genes & Development, 5, 1333–1344.
14. Duester, G. (2008). Retinoic acid synthesis and signaling during
early organogenesis. Cell, 134, 921–931.
15. Sandell, L. L., Sanderson, B. W., Moiseyev, G., et al. (2007).
RDH10 is essential for synthesis of embryonic retinoic acid and
is required for limb, craniofacial, and organ development. Genes &
Development, 21, 1113–1124.
16. Matt, N., Dupe, V., Garnier, J. M., et al. (2005). Retinoic acid-
dependent eye morphogenesis is orchestrated by neural crest cells.
Development, 132, 4789–4800.
17. Hauser, S., Widera, D., Qunneis, F.A., et al. (2011). Isolation of
novel multipotent neural crest-derived stem cells from adult human
inferior turbinate. Stem Cells and Development.
18. Widera, D., Grimm, W. D., Moebius, J. M., et al. (2007). Highly
efficient neural differentiation of human somatic stem cells, isolat-
ed by minimally invasive periodontal surgery. Stem Cells and
Development, 16, 447–460.
19. Widera, D., Zander, C., Heidbreder, M., et al. (2009). Adult pala-
tum as a novel source of neural crest-related stem cells. Stem Cells,
27, 1899–1910.
20. Kaltschmidt, B., Kaltschmidt, C., Widera, D. (2011). Adult craniofa-
cial stem cells: sources and relation to the neural crest. Stem Cell Rev.
21. Kawaguchi, J., Mee, P. J., & Smith, A. G. (2005). Osteogenic and
chondrogenic differentiation of embryonic stem cells in response
to specific growth factors. Bone, 36, 758–769.
22. Kawaguchi, J., Nichols, J., Gierl, M. S., Faial, T., & Smith, A.
(2010). Isolation and propagation of enteric neural crest progenitor
cells from mouse embryonic stem cells and embryos.
Development, 137, 693–704.
23. Lee, G., Chambers, S. M., Tomishima, M. J., & Studer, L. (2010).
Derivation of neural crest cells from human pluripotent stem cells.
Nature Protocols, 5, 688–701.
24. Lee, G., Papapetrou, E. P., Kim, H., et al. (2009). Modelling
pathogenesis and treatment of familial dysautonomia using
patient-specific iPSCs. Nature, 461, 402–406.
25. Sauka-Spengler, T., & Bronner-Fraser, M. (2008). A gene regula-
tory network orchestrates neural crest formation. Nature Reviews
Molecular Cell Biology, 9, 557–568.
26. Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009).
Epithelial-mesenchymal transitions in development and disease.
Cell, 139, 871–890.
27. Barton, D., HogenEsch, H., & Weih, F. (2000). Mice lacking the
transcription factor RelB develop T cell-dependent skin lesions
similar to human atopic dermatitis. European Journal of
Immunology, 30, 2323–2332.
28. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D.
(1995). Embryonic lethality and liver degeneration in mice lacking
the RelA component of NF-kappa B. Nature, 376, 167–170.
29. Li, Q., Estepa, G., Memet, S., Israel, A., & Verma, I. M. (2000).
Complete lack of NF-kappaB activity in IKK1 and IKK2 double-
deficient mice: additional defect in neurulation. Genes &
Development, 14, 1729–1733.
30. Ruland, J., Duncan, G. S., Elia, A., et al. (2001). Bcl10 is a positive
regulator of antigen receptor-induced activation of NF-kappaB and
neural tube closure. Cell, 104, 33–42.
31. Mansouri, A., & Gruss, P. (1998). Pax3 and Pax7 are expressed in
commissural neurons and restrict ventral neuronal identity in the
spinal cord. Mechanisms of Development, 78, 171–178.
32. Schorle, H., Meier, P., Buchert, M., Jaenisch, R., & Mitchell, P. J.
(1996). Transcription factor AP-2 essential for cranial closure and
craniofacial development. Nature, 381, 235–238.
33. Sosic, D., Richardson, J. A., Yu, K., Ornitz, D. M., & Olson, E. N.
(2003). Twist regulates cytokine gene expression through a nega-
tive feedback loop that represses NF-kappaB activity. Cell, 112,
169–180.
34. Carver, E. A., Jiang, R., Lan, Y., Oram, K. F., & Gridley, T. (2001).
The mouse snail gene encodes a key regulator of the epithelial-
mesenchymal transition. Molecular and Cellular Biology, 21,
8184–8188.
35. Roth, S., Stein, D., & Nusslein-Volhard, C. (1989). A gradient of
nuclear localization of the dorsal protein determines dorsoventral
pattern in the Drosophila embryo. Cell, 59, 1189–1202.
36. Hong, J. W., Hendrix, D. A., Papatsenko, D., & Levine, M. S.
(2008). How the Dorsal gradient works: insights from postgenome
technologies. Proceedings of the National Academy of Sciences of
the United States of America, 105, 20072–20076.
37. De Robertis, E. M., & Sasai, Y. (1996). A common plan for
dorsoventral patterning in Bilateria. Nature, 380, 37–40.
38. Qin, X. F., An, D. S., Chen, I. S., & Baltimore, D. (2003). Inhibiting
HIV-1 infection in human T cells by lentiviral-mediated delivery of
small interfering RNA against CCR5. Proceedings of the National
Academy of Sciences of the United States of America, 100, 183–188.
1108 Stem Cell Rev and Rep (2012) 8:1098–1108
